Remedy Informatics, Inc., a provider of registries and integrated research management systems for healthcare and life science research, has raised roughly $6m in funding from the Merck Global Health Innovation Fund (GHIF).
In conjunction with the funding, Merck Global Health Innovation Fund will take a seat on the company’s Board of Directors.
the company intends to use the capital to invest in its Mosaic™ Platform and grow in the U.S. and expand into Europe and Latin America.
Led by Gary Kennedy, Founder & CEO, Remedy Informatics provides clinical registries, medical research software, and research informatics products.
In details, the company offerings include:
- the Investigate™ integrated research management system that integrates data flows and analytics across the lab, clinic and biobank settings.
- ComprehensiveOncology™ (suite of solid tumor and blood cancer registries),
- ComprehensiveBMT™ (blood and marrow transplant registry),
- RemedyJoint™ (total joint replacement registry).
The company serves a wide range of life science and healthcare institutions including Cleveland Clinic’s Heart and Vascular Institute, Massachusetts General Hospital, Baylor Health Care System, Princess Margaret Cancer Centre in Toronto, Indiana University and the Indiana Clinical and Translational Science Institute, Genentech and others.